Literature DB >> 8108926

Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis.

M Green1, J Reyes, B Nour, D Beatty, M Kaufman, J Wilson, S Todo, A Tzakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8108926

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Authors:  Javier Bueno; Carmen Ramil; Michael Green
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Cytomegalovirus infection after intestinal transplantation in children.

Authors:  J Bueno; M Green; S Kocoshis; H Furukawa; K Abu-Elmagd; E Yunis; W Irish; S Todo; J Reyes; T E Starzl
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 4.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 5.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.